Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Helicobacter Pylori | Research article

Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer

Authors: Li-cong Ma, Xu-yang Tian, Fang Gao, Wen-jie Dong, Tong Dang, Yan-bin Jia

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

Many studies have found that large tumor suppressor kinase 1 (LATS1) and LATS2 play important roles in many diseases, but studies have been rare on the relationship between these genes and non-cardia gastric cancer (GC). We performed a case-control association study to investigate the associations between single nucleotide polymorphisms (SNPs) in LATS1 and LATS2 genes and Helicobacter pylori (H. pylori) infection as well as the risk of non-cardia GC.

Methods

First, H. pylori infection was determined by the serological test using enzyme-linked immunoassay. Then genotyping of SNPs was performed for 808 samples by the Taqman method. Finally, unconditional logistic regression was used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for age and gender, for the association of each SNP with the infection of H. pylori, the risk of non-cardia gastric cancer, as well as the expression of LATS1 and LATS2 proteins in non-cardia GC tissues, using the codominant, dominant, recessive, overdominant, and log-additive inheritance models, respectively.

Results

The statistical results showed that LATS2 rs9552315 was associated with H. pylori infection, and the CC + CT genotype could reduce the risk of H. pylori infection (odds ratio [OR]: 0.549, 95% confidence interval [CI]: 0.339–0.881, P < 0.05) compared with the TT genotype in a dominant model. LATS1 rs9393175 was associated with the risk of non-cardia GC, and the AG genotype reduced the risk of non-cardia GC (OR: 0.702, 95% CI: 0.516–0.952, P < 0.05) compared with the GG + AA genotype in an overdominant model. LATS2 rs9509492 was associated with the risk of GC in an log-additive model. No associations were found between five SNPs and expression of LATS1 and LATS2 proteins in non-cardia GC tissue.

Conclusions

LATS2 rs9552315 CT genotype may be a protective factor against infection of H. pylori. LATS1 rs9393175 AG genotype and LATS2 rs9509492 GG genotype may be protective factors for non-cardia GC.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
go back to reference Lu B, Li M. Helicobacter pylori eradication for preventing gastric cancer. World J Gastroenterol. 2014;20(19):5660–5.CrossRef Lu B, Li M. Helicobacter pylori eradication for preventing gastric cancer. World J Gastroenterol. 2014;20(19):5660–5.CrossRef
3.
go back to reference Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
4.
go back to reference de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–15.CrossRef de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–15.CrossRef
5.
go back to reference Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345(2):196–202.CrossRef Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345(2):196–202.CrossRef
6.
go back to reference Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713–39.CrossRef Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713–39.CrossRef
7.
go back to reference Xiao FK, Yang JX, Li XM, Zhao XK, Zheng PY, Wang LD. Interaction of 22 risk SNPs with helicobacter pylori infection and risk of gastric cardia adenocarcinoma. Future Oncol. 2019;15(31):3579–85.CrossRef Xiao FK, Yang JX, Li XM, Zhao XK, Zheng PY, Wang LD. Interaction of 22 risk SNPs with helicobacter pylori infection and risk of gastric cardia adenocarcinoma. Future Oncol. 2019;15(31):3579–85.CrossRef
8.
go back to reference Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121(4):1053–63.PubMed Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121(4):1053–63.PubMed
9.
go back to reference Ji XY, Zhong G, Zhao B. Molecular mechanisms of the mammalian hippo signaling pathway. Yi Chuan. 2017;39(7):546–67.PubMed Ji XY, Zhong G, Zhao B. Molecular mechanisms of the mammalian hippo signaling pathway. Yi Chuan. 2017;39(7):546–67.PubMed
10.
go back to reference Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19(4):491–505.CrossRef Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19(4):491–505.CrossRef
11.
go back to reference Wang Y, Yu A, Yu FX. The hippo pathway in tissue homeostasis and regeneration. Protein Cell. 2017;8(5):349–59.CrossRef Wang Y, Yu A, Yu FX. The hippo pathway in tissue homeostasis and regeneration. Protein Cell. 2017;8(5):349–59.CrossRef
12.
go back to reference Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, et al. Expression of LATS family proteins in ovarian tumors and its significance. Hum Pathol. 2015;46(6):858–67.CrossRef Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, et al. Expression of LATS family proteins in ovarian tumors and its significance. Hum Pathol. 2015;46(6):858–67.CrossRef
13.
go back to reference Malik SA, Khan MS, Dar M, Hussain MU, Shah MA, Shafi SM, et al. Molecular alterations and expression dynamics of LATS1 and LATS2 genes in non-small-cell lung carcinoma. Pathol Oncol Res. 2018;24(2):207–14.CrossRef Malik SA, Khan MS, Dar M, Hussain MU, Shah MA, Shafi SM, et al. Molecular alterations and expression dynamics of LATS1 and LATS2 genes in non-small-cell lung carcinoma. Pathol Oncol Res. 2018;24(2):207–14.CrossRef
14.
go back to reference Ma L, Tian X, Gao F, Liu D, Dang T, Bai X, et al. Expressions of large tumor suppressor kinase 1 and large tumor suppressor kinase 2 in gastric cancer and their significances. Cancer Research and Clinic. 2019;31(2):93–7. Ma L, Tian X, Gao F, Liu D, Dang T, Bai X, et al. Expressions of large tumor suppressor kinase 1 and large tumor suppressor kinase 2 in gastric cancer and their significances. Cancer Research and Clinic. 2019;31(2):93–7.
15.
go back to reference Kim SH, Jin H, Meng RY, Kim DY, Liu YC, Chai OH, et al. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis ofGastric Cancer. Int J Mol Sci. 2019;20(19):4709. Kim SH, Jin H, Meng RY, Kim DY, Liu YC, Chai OH, et al. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis ofGastric Cancer. Int J Mol Sci. 2019;20(19):4709.
16.
go back to reference Shen L, Wen J, Zhao T, Hu Z, Song C, Gu D, et al. A genetic variant in large tumor suppressor kinase 2 of hippo signaling pathway contributes to prognosis of hepatocellular carcinoma. Onco Targets Ther. 2016;9:1945–51.PubMedPubMedCentral Shen L, Wen J, Zhao T, Hu Z, Song C, Gu D, et al. A genetic variant in large tumor suppressor kinase 2 of hippo signaling pathway contributes to prognosis of hepatocellular carcinoma. Onco Targets Ther. 2016;9:1945–51.PubMedPubMedCentral
17.
go back to reference Sebio A, Matsusaka S, Zhang W, Yang D, Ning Y, Stremitzer S, et al. Germline polymorphisms in genes involved in the hippo pathway as recurrence biomarkers in stages II/III colon cancer. Pharm J. 2016;16(4):312–9. Sebio A, Matsusaka S, Zhang W, Yang D, Ning Y, Stremitzer S, et al. Germline polymorphisms in genes involved in the hippo pathway as recurrence biomarkers in stages II/III colon cancer. Pharm J. 2016;16(4):312–9.
18.
go back to reference Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, et al. Positive serum antibody and negative tissue staining for helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology. 1991;101(1):167–74.CrossRef Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, et al. Positive serum antibody and negative tissue staining for helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology. 1991;101(1):167–74.CrossRef
19.
go back to reference Farinati F, Valiante F, Germana B, Della Libera G, Baffa R, Rugge M, et al. Prevalence of helicobacter pylori infection in patients with precancerous changes and gastric cancer. Eur J Cancer Prev. 1993;2(4):321–6.CrossRef Farinati F, Valiante F, Germana B, Della Libera G, Baffa R, Rugge M, et al. Prevalence of helicobacter pylori infection in patients with precancerous changes and gastric cancer. Eur J Cancer Prev. 1993;2(4):321–6.CrossRef
Metadata
Title
Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer
Authors
Li-cong Ma
Xu-yang Tian
Fang Gao
Wen-jie Dong
Tong Dang
Yan-bin Jia
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01250-x

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue